RISTELTA Trademark

Trademark Overview

On Tuesday, January 28, 2014, a trademark application was filed for RISTELTA with the United States Patent and Trademark Office. The USPTO has given the RISTELTA trademark a serial number of 86177382. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 25, 2017. This trademark is owned by Glaxo Group Limited. The RISTELTA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
ristelta

General Information

Serial Number86177382
Word MarkRISTELTA
Filing DateTuesday, January 28, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 25, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 23, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "RISTELTA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 7, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Tuesday, December 26, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, December 25, 2017ABANDONMENT - NO USE STATEMENT FILED
Friday, May 5, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 4, 2017EXTENSION 5 GRANTED
Thursday, April 27, 2017EXTENSION 5 FILED
Thursday, April 27, 2017TEAS EXTENSION RECEIVED
Friday, October 28, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 27, 2016EXTENSION 4 GRANTED
Thursday, October 13, 2016EXTENSION 4 FILED
Thursday, October 13, 2016TEAS EXTENSION RECEIVED
Tuesday, May 17, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, May 14, 2016EXTENSION 3 GRANTED
Thursday, April 14, 2016EXTENSION 3 FILED
Thursday, May 12, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 14, 2016TEAS EXTENSION RECEIVED
Thursday, October 29, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 28, 2015EXTENSION 2 GRANTED
Monday, October 19, 2015EXTENSION 2 FILED
Wednesday, October 28, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 19, 2015TEAS EXTENSION RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 2, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 31, 2015EXTENSION 1 GRANTED
Tuesday, March 31, 2015EXTENSION 1 FILED
Tuesday, March 31, 2015TEAS EXTENSION RECEIVED
Tuesday, November 18, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 23, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 23, 2014PUBLISHED FOR OPPOSITION
Wednesday, September 3, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 19, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, August 14, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 13, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 13, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 6, 2014ASSIGNED TO LIE
Monday, August 4, 2014TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, April 23, 2014NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, April 23, 2014LETTER OF SUSPENSION E-MAILED
Wednesday, April 23, 2014SUSPENSION LETTER WRITTEN
Tuesday, April 22, 2014ASSIGNED TO EXAMINER
Friday, February 7, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, January 31, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

ristelta pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological